Drug delivery in biotechnology: present and future.

Drug delivery is becoming a whole interdisciplinary and independent field of research and is gaining the attention of pharmaceutical makers, medical doctors and industry. A targeted and safe drug delivery could improve the performance of some classical medicines already on the market and, moreover, will have implications for the development and success of new therapeutic strategies, such as peptide and protein delivery, glycoprotein administration, gene therapy and RNA interference. Many innovative technologies for effective drug delivery have been developed, including implants, nanotechnology, cell and peptide encapsulation, microfabrication, chemical modification and others. On the long way from the clinic to market, however, several issues will have to be addressed, including suitable scientific development, specific financial support as a result of altered scientific policy, government regulations and market forces.

[1]  E Marshall,et al.  Gene Therapy Death Prompts Review of Adenovirus Vector , 1999, Science.

[2]  Robert Langer,et al.  Small-scale systems for in vivo drug delivery , 2003, Nature Biotechnology.

[3]  P. Vos,et al.  Cell encapsulation: Promise and progress , 2003, Nature Medicine.

[4]  A. Gabizon.  Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy , 2001, Cancer investigation.

[5]  Vladimir P Torchilin,et al.  Peptide and protein drug delivery to and into tumors: challenges and solutions. , 2003, Drug Discovery Today.

[6]  A. Florence,et al.  Studies on the uptake of tomato lectin nanoparticles in everted gut sacs. , 1999, International journal of pharmaceutics.

[7]  Veronese Fm,et al.  Introduction and overview of peptide and protein pegylation. , 2002 .

[8]  G. Weir,et al.  Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. , 2001, Diabetes.

[9]  Schipper,et al.  Cyclodextrins in nasal drug delivery. , 1999, Advanced drug delivery reviews.

[10]  G. Grant,et al.  Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects , 1985, FEBS letters.

[11]  P. de Vos,et al.  Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. , 2002, Trends in molecular medicine.

[12]  John Rossi,et al.  Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  Erika Check,et al.  Gene regulation: RNA to the rescue? , 2003, Nature.

[14]  Weng Tao,et al.  Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. , 2002, Investigative ophthalmology & visual science.

[15]  Jörg Maser,et al.  Biology of TiO2–oligonucleotide nanocomposites , 2003, Nature materials.

[16]  Paroma Basu.  News Feature: Technologies that deliver , 2003, Nature Medicine.

[17]  N. Déglon,et al.  Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  M. Allen,et al.  Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.

[19]  Jeffrey Bonadio,et al.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.

[20]  M. Allen,et al.  Microfabricated microneedles for gene and drug delivery. , 2000, Annual review of biomedical engineering.

[21]  S. Davis,et al.  Chitosan as a novel nasal delivery system for vaccines. , 2001, Advanced drug delivery reviews.

[22]  Robert Langer,et al.  Moving smaller in drug discovery and delivery , 2002, Nature Reviews Drug Discovery.

[23]  M. Bentley,et al.  Chemistry for peptide and protein PEGylation. , 2002, Advanced drug delivery reviews.

[24]  W. Shen.  Oral peptide and protein delivery: unfulfilled promises? , 2003, Drug discovery today.

[25]  P. Soon-Shiong,et al.  Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation , 1994, The Lancet.

[26]  L. Defrancesco.  Little science, big bucks , 2003, Nature Biotechnology.

[27]  A. Al-Hendy,et al.  Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. , 1996, Blood.

[28]  N. Yang,et al.  Gene gun and other non-viral approaches for cancer gene therapy , 1995, Nature Medicine.

[29]  D. Maysinger,et al.  Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles , 2003, Science.

[30]  M. Peschanski,et al.  Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease , 1997, Nature.

[31]  L. Illum.  Nasal drug delivery: new developments and strategies. , 2002, Drug discovery today.

[32]  T. A. Desai,et al.  Micro- and nanoscale structures for tissue engineering constructs. , 2000, Medical engineering & physics.

[33]  J. Neuberger,et al.  A Bioartificial Liver--State of the Art , 2002, Science.

[34]  Tatsuya Kin,et al.  Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression1 , 2003, Transplantation.

[35]  M Rothmund,et al.  Parathyroid allotransplantation without immunosuppression , 1997, The Lancet.

[36]  M. Löhr,et al.  Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma , 2001, The Lancet.

[37]  R. Langer,et al.  Where a pill won't reach. , 2003, Scientific American.

[38]  T. Desai,et al.  Microfabricated drug delivery systems: from particles to pores. , 2003, Advanced drug delivery reviews.

[39]  M. Roco.  Nanotechnology: convergence with modern biology and medicine. , 2003, Current opinion in biotechnology.

[40]  M. Cima,et al.  A controlled-release microchip , 1999, Nature.

[41]  J. Pedraz,et al.  Microencapsulation of an anti-VE-cadherin antibody secreting 1B5 hybridoma cells. , 2001, Biotechnology and bioengineering.

[42]  R. Timpl,et al.  Local endostatin treatment of gliomas administered by microencapsulated producer cells , 2001, Nature Biotechnology.

[43]  G. Orive,et al.  Cell microencapsulation technology for biomedical purposes: novel insights and challenges. , 2003, Trends in pharmacological sciences.